Cordant Health Solutions® offers a managed pharmacy program that focuses on supporting clinicians who treat patients for opioid use disorder using buprenorphine and other medications. The program works by delivering buprenorphine dispensed by Cordant’s pharmacy to the patient during the time of their treatment visit or for telemedicine programs, to the patient’s home.
Cordant’s on-site buprenorphine program eliminates many of the barriers to treatment that patients face including poor treatment at retail pharmacies, challenges with transportation and limited or no availability of medication when needed, and can help improve patient adherence to their treatment plan.
In a recent survey, 92% of patients said that are more likely to adhere to their treatment plans and attend their appointments when they receive buprenorphine medication at their doctor’s office through Cordant’s program, and 98% said they feel that Cordant’s pharmacy coordinators treat them with respect and care about their well-being.
Based on 714 patient responses from an ongoing patient experience survey May-Aug. 2020
NPS is a measure of customer satisfaction and loyalty, with scores over 50 considered “best in class.” Cordant scored 83, which is higher than many popular beloved brands like Southwest (71), Costco (76), and USAA (72).
Patients in Cordant’s buprenorphine program showed significantly higher retention rates, especially in the early part of treatment
Patients in Cordant’s program had fewer drug-related ER visits
Patients in Cordant’s program experienced fewer relapse events
Source: Analysis of 154 patients 90 days or less in treatment prior to Cordant’s clinic-based managed pharmacy program; Nov. 2016–Oct. 2017 and 154 patients 90 days or less in treatment participating in program; Nov. 2017–Oct. 2018
Please complete this form to request more information about our managed pharmacy solution.